The Kingdom Specialty Enzymes Market is
anticipated to grow at a significant rate during the projected period, 2024-2028.
Specialty enzymes are a diverse group of enzymes that possess unique properties
and functions, making them suitable for specific applications in various
industries. Collaborative research and development initiatives have been
instrumental in driving the growth of specialty enzymes market in the country.
Academic institutions, research organizations, and industry players are joining
forces to explore novel enzymes, optimize enzyme properties, and discover new
applications. These collaborations help bridge the gap between academic
research and industrial implementation, accelerating the development of
innovative specialty enzymes and their commercialization. In line with global
sustainability goals, the UK has placed increasing emphasis on adopting
eco-friendly practices and reducing environmental impact. Specialty enzymes
offer significant advantages in terms of biodegradability, efficiency, and
specificity compared to traditional chemical processes. Industries such as
biofuels, waste management, and bioremediation rely on specialty enzymes to
develop sustainable solutions. The UK's commitment to environmental
sustainability acts as a catalyst for the adoption of specialty enzymes in
these sectors.
The shift towards personalized medicine, where
treatments are tailored to individual patients, presents new opportunities for
specialty enzymes. Enzymes are crucial in diagnostics and therapeutic
applications, enabling precision medicine approaches. Enzymes such as
polymerases, ligases, and proteases are utilized in DNA sequencing, genetic
testing, and targeted therapies. The growing adoption of personalized medicine
in the United Kingdom fuels the demand for specialty enzymes with specific
functions and high purity.
The United Kingdom's food and beverage industry
is dynamic and continuously evolving to meet changing consumer preferences.
Specialty enzymes find extensive applications in this sector, including food
processing, flavor enhancement, and ingredient modification. Enzymes such as
amylases, lipases, and proteases are utilized to improve food texture, enhance
nutritional profiles, and develop innovative food products. The demand for
specialty enzymes in the food and beverage industry is driven by the need for
cleaner labels, improved functionality, and enhanced product quality.
Additionally, the United Kingdom has a thriving pharmaceutical industry that
continues to evolve and innovate. Specialty enzymes find extensive application
in drug discovery, production, and formulation processes. Enzymes such as
proteases, kinases, and polymerases are used in research, diagnostics, and the
manufacturing of biopharmaceuticals. The growth of the pharmaceutical sector,
coupled with increasing research and development activities, fuels the demand
for specialty enzymes in the United Kingdom. Furthermore, the expanding range
of applications for specialty enzymes has been a crucial growth driver.
Initially utilized in traditional industries like food processing and textiles,
specialty enzymes are now finding applications in emerging sectors such as
personalized medicine, biopharmaceuticals, and diagnostics. Specialty enzymes
play a pivotal role in the development and production of therapeutics, DNA
sequencing, immunoassays, and molecular diagnostics. As industries recognize
the value and versatility of specialty enzymes, the demand for these enzymes
continues to grow. Collaborative research and development initiatives have been
instrumental in driving the growth of specialty enzymes. Academic institutions,
research organizations, and industry players are joining forces to explore
novel enzymes, optimize enzyme properties, and discover new applications. These
collaborations help bridge the gap between academic research and industrial implementation,
accelerating the development of innovative specialty enzymes and their
commercialization.
Advancements in
Biotechnology and Genetic Engineering are Driving the Market
The key growth driver for
specialty enzymes market is the continuous progress in biotechnology and
genetic engineering techniques. These advancements have revolutionized enzyme
production by enabling the development of robust and efficient enzyme
production systems. Through recombinant DNA technology and metabolic engineering,
researchers can engineer microorganisms to produce high yields of specialty
enzymes economically. This increased efficiency and scalability has made
specialty enzymes more accessible and cost-effective for industries. The quick
advancement of gene engineering technology makes it possible to alter
biological processes at the molecular level. The use of biotechnology in agriculture and
medical research is growing. Enzymes have a variety of roles in medical
research, including the development of new drugs, the treatment of diseases,
and the diagnosis or prognosis of illnesses. For easier testing and diagnosis,
enzymes can also be added to assay kits, such as coupled multi-enzyme assay
kits and enzyme-linked immunosorbent assay (ELISA) kits.
Growing Use of Speciality
Enzymes in Biopharmaceuticals Industry
The biopharmaceutical industry has experienced
remarkable growth, and specialty enzymes have played a significant part in this
expansion. Specialty enzymes are indispensable in the production of biologics,
including therapeutic proteins, antibodies, and vaccines. The increasing
prevalence of complex diseases, coupled with advancements in biotechnology and
recombinant DNA technology, has fueled the demand for specialty enzymes in the pharmaceutical
sector. As the biopharmaceutical market continues to thrive, the demand for
specialty enzymes will likely follow suit. According to the European
Chemical Industry Council, chemicals, and pharmaceuticals were the UK's
second-largest manufacturing sector in 2021, trailing only machinery and
transport equipment, with exports exceeding USD54 billion and value added to
the economy of USD30.7 billion. Moreover, many medications have chiral
preferences; as a result, the synthesis and development of chiral compounds are
essential steps in the production of pharmaceuticals. In place of chemical
catalysis, deploying enzymes has gained popularity in recent years for chiral
resolution. The great selectivity and specificity of enzymatic reactions give
the enzymatic pathway an advantage in this application. The byproducts of
chemically catalyzed reactions frequently include optical isomers with both R-
and S- orientations. In contrast, enzymes can quickly produce chiral and pure
molecules, resolving a long-standing issue with conventional chemical
synthesis.
Mergers & Acquisitions
· In January 2023, BASF and Cargill announced their expanded
cooperation. The partnership will allow the merging of BASF's strengths in
enzyme research and development with Cargill's expertise in application and
wide market reach. Additionally, both enterprises are dedicated to bringing
cutting-edge enzyme-based solutions to the market and creating unique value for
consumers of animal feed.
· In June 2021, the innovative second-generation protease ProAct
360TM was commercially released by DSM and Novozymes Feed Enzymes Alliance.
ProAct 360TM sets a new industry standard for poultry protease technology,
offering improved feed effectiveness, cost-effectiveness, and sustainability.
This cutting-edge feed formulation provides faster action, better matrix values
for essential amino acids, and more consistent gains in growth performance.
Recent Developments
· In November 2022, a prominent player in the industry, Amano
Enzyme, Inc., confirmed its new establishment at Milton Park, a science,
technology, and business community in Oxfordshire, United Kingdom. This new hub
will house a cutting-edge laboratory equipped with state-of-the-art technology
and equipment. These resources will aid the company in expanding its position
into various other areas, such as plant-based food and drinks.
· In November 2021, Novozymes and Novo Nordisk Pharmatech announced
a collaboration to develop high-quality enzymatic processing aids for the
regenerative medicines market, with a focus on stem cell and gene therapies.
Additionally, in March 2021, Novo Nordisk Pharmatech launched a superior Good
Manufacturing Practice (GMP) grade recombinant trypsin in anticipation of
expanding their portfolio by introducing more enzymes and purification resins
in the future.
Market Segmentation
United Kingdom Specialty
Enzymes Market is segmented into Type, Source, Application, Region, and Competitive
Landscape. Based on Type, the market is divided into Proteases, Polymerases
& Nucleases, Carbohydrases, Lipases, and Others. Based on Source, the
market is divided into Microorganisms, Plants, and Animals. Based on Application,
the market is divided into Biotechnology, Pharmaceuticals, Diagnostics, and
Research & Development. Based on Region, the market is segmented into Scotland,
South-East, London, South-West, East-Anglia, Yorkshire & Humberside, and
East Midlands and Rest of the United Kingdom.
Company Profiles
Amano Enzyme Europe Limited, BASF SE, Codexis, Inc.
(CDXS), DSM Nutritional Products (UK) Limited, Novozymes UK Limited,
BRAIN Biotech AG, Biocatalysts Ltd., Kerry Inc., DuPont (U.K.) Ltd. and Chr.
Hansen Holding A/S are some of the key players in United Kingdom Specialty
Enzymes Market.
Download Free Sample Report
|
Attribute
|
Details
|
|
Base
Year
|
2022
|
|
Historic Data
|
2018 – 2021
|
|
Estimated
Year
|
2023
|
|
Forecast Period
|
2024 – 2028
|
|
Quantitative
Units
|
Revenue in USD Million and CAGR for 2018-2022 and 2023-2028
|
|
Report coverage
|
Revenue forecast, company
shares, competitive landscape, growth factors, and trends
|
|
Segments
covered
|
Type
Source
Application
|
|
Regional scope
|
Scotland, South-East,
London, South-West, East-Anglia, Yorkshire & Humberside, East Midlands and
Rest of United Kingdom.
|
|
Key companies profiled
|
Amano Enzyme Europe Limited, BASF SE,
Codexis, Inc. (CDXS), DSM
Nutritional Products (UK) Limited, Novozymes UK Limited, BRAIN Biotech AG,
Biocatalysts Ltd., Kerry Inc., DuPont (U.K.) Ltd. and Chr. Hansen Holding A/S
|
|
Customization
scope
|
10% free report customization with purchase. Addition or alteration
to country, regional & segment scope.
|
|
Pricing and purchase options
|
Avail customized purchase
options to meet your exact research needs.
|
|
Delivery
Format
|
PDF and Excel through Email (We can
also provide the editable version of the report in PPT/Word format on special
request)
|
Report Scope:
In this report, United Kingdom Specialty
Enzymes Market has been segmented into the following categories, in addition to
the industry trends, which have also been detailed below:
·
United Kingdom Specialty Enzymes Market,
By Type:
o
Proteases
o
Polymerases & Nucleases
o
Carbohydrases
o
Lipases
o
Others
·
United Kingdom Specialty Enzymes Market, By Source:
o
Microorganisms
o
Plants
o
Animals
·
United Kingdom Specialty Enzymes Market, By Application:
o
Biotechnology
o
Pharmaceuticals
o
Diagnostics
o
Research & Development
·
United Kingdom Specialty Enzymes Market, By Region:
o Scotland
o South-East
o London
o South-West
o East-Anglia
o Yorkshire
& Humberside
o East
Midlands
o Rest
of United Kingdom
Competitive landscape
Company Profiles: Detailed analysis of the
major companies in United Kingdom Specialty Enzymes Market.
Available Customizations:
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following customization
options are available for the report:
Company Information
·
Detailed analysis and profiling of additional market players (up
to five).
United Kingdom Specialty
Enzymes Market is an upcoming report to be released soon. If you wish an early
delivery of this report or want to confirm the date of release, please contact
us at [email protected].